PAPER Selkoe DJ

Resolving controversies on the path to Alzheimer's therapeutics.

Nat Med. 2011;17(12):1693. PubMed.

PAPER Bennys K, Rondouin G, Benattar E, Gabelle A, Touchon J

Can event-related potential predict the progression of mild cognitive impairment?

J Clin Neurophysiol. 2011 Dec;28(6):625-32. PubMed.

PAPER Tardiff DF, Tucci ML, Caldwell KA, Caldwell GA, Lindquist S

Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms.

J Biol Chem. 2012 Feb 3;287(6):4107-20. PubMed.

PAPER

Correction for Kiyota et al., FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.

Am J Alzheimers Dis Other Demen. 2011 Nov;26(7):510. PubMed.

PAPER Kingwell K

Alzheimer disease: Amyloid-targeting antibody performs well in phase II trial.

Nat Rev Neurol. 2011 Dec;7(12):657. PubMed.

PAPER Redcay E, Dodell-Feder D, Pearrow MJ, Mavros PL, Kleiner M, Gabrieli JD, Saxe R

Live face-to-face interaction during fMRI: a new tool for social cognitive neuroscience.

Neuroimage. 2010 May 1;50(4):1639-47. PubMed.

PAPER Montague PR, Berns GS, Cohen JD, McClure SM, Pagnoni G, Dhamala M, Wiest MC, Karpov I, King RD, Apple N, Fisher RE

Hyperscanning: simultaneous fMRI during linked social interactions.

Neuroimage. 2002 Aug;16(4):1159-64. PubMed.

John Morris on Testing the right target and right drug at the right stage.

COMMENT I am unaccustomed to posting comments in an online scientific debate, in this case regarding the challenge posed by Reisa Sperling, Clifford Jack, and Paul Aisen to conduct clinical trials of potential Alzheimer's therapies in the preclinical (presym

Yousuf Ali

University of Pennsylvania
Philadelphia, United States

DC: In a Scanner Made for Two, Dual Scan Shows Mental Coupling

CONFERENCE COVERAGE 2011-12-08 Conference Coverage First, it was bicycles. Now, it’s magnetic resonance imagers. A dual-head functional magnetic resonance (fMRI) detection system developed by Ray Lee of Princeton University in New Jersey is the first to allow brain imaging of two peopl

PAPER Kanagasundram S

[Schizophrenia or Frontotemporal Dementia in a Young Chinese Female: A purview of possible diagnoses].

Turk Psikiyatri Derg. 2011 Winter;22(4):266-8. PubMed.

PAPER Peña-Oliver Y, Buchman VL, Dalley JW, Robbins TW, Schumann G, Ripley TL, King SL, Stephens DN

Deletion of alpha-synuclein decreases impulsivity in mice.

Genes Brain Behav. 2012 Mar;11(2):137-46. PubMed.

PAPER McGeer PL, McGeer EG

History of innate immunity in neurodegenerative disorders.

Front Pharmacol. 2011;2:77. PubMed.

PAPER Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A

Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.

PLoS One. 2011;6(12):e28032. PubMed.

PAPER Kou X, Shen K, An Y, Qi S, Dai WX, Yin Z

Ampelopsin Inhibits H(2) O(2)-induced Apoptosis by ERK and Akt Signaling Pathways and Up-regulation of Heme Oxygenase-1.

Phytother Res. 2011 Dec 6; PubMed.